Medisinsk forskning på cannabis
I dette arkivet finner du over 15 000 lenker til forskningsartikler og studier på cannabis planten. Listen er på engelsk, delt opp i medisinske lidelser og andre kategorier i alfabetisk rekkefølge.
NB! Sidene på hver bokstav kan laste tregt da tusenvis av linker lastes
C
CACHEXIA (9)
-
Nutritional Interventions for Cancer-induced Cachexia
-
The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world
-
Clinical evaluation and optimal management of cancer cachexia
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Cannabis â therapy for the future?
-
Sex Differences in Cannabinoid-Regulated Biology: A Focus on Energy Homeostasis
-
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome
-
Cachexia
-
A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9- tetrahydrocannabinol, elicits hyperphagia in rats
CAFFEINE and the ENDOCANNABINOID SYSTEM (5)
-
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors
-
Combined effects of THC and caffeine on working memory in rats
-
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Î9-tetrahydrocannabinol on spatial memory
-
The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance
-
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)
CANCER-ADENOCARCINOMA (4)
-
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists
-
Effect of anandamide on endometrial adenocarcinoma (Ishikawa) cell numbers: implications for endometrial cancer therapy
-
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells
-
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
CANCER-BLADDER/URETHRAL (6)
-
TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer
-
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells
-
Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladder
-
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
-
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Menâs Health Study
-
Endocannabinoid system as a regulator of tumor cell malignancy â biological pathways and clinical significance
CANCER-BONE (23)
-
Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain
-
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss
-
The endocannabinoid system and cancer: therapeutic implication
-
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain
-
Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model
-
New targets, new drugs for metastatic bone pain: a new philosophy
-
Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice
-
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
-
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists
-
Antimetastatic activity of honokiol in osteosarcoma
-
Role of cannabinoid 2 receptor in the development of bone cancer pain
-
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain
-
Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line
-
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models
-
Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain
-
Involvement of PAR-4 in Cannabinoid-Dependent Sensitization of Osteosarcoma Cells to TRAIL-Induced Apoptosis
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2
-
The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells
-
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord
-
A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2
-
Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2
-
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma
CANCER-BREAST (57)
-
Anxiety Associated with Dying
-
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
-
A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
-
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Rasfarnesylation mediate antitumor effects of anandamide in human breast cancer cells
-
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)
-
Peripheral cannabinoid type 2 receptor regulates osteoclast formation, MDA-MB-231 breast cancer cell migration and bone marrow/tumour cell interaction via PI3 kinase/AKT and P38 pathways
-
The endocannabinoid system and cancer: therapeutic implication
-
Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion
-
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the crosstalk between apoptosis and autophagy
-
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
-
The effect of CBD (BDS) botanical cannabinoid extraction on MCF-7 human breast carcinoma cells
-
L-α-lysophosphatidylinositol meets GPR55: a deadly relationship
-
Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis
-
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines
-
The CB2 receptor regulates osteoclast formation, breast cancer cell migration and osteoclast / tumour cell interaction via the PI3 Kinase/AKT pathway
-
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists
-
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
-
Cannabinoids: A new hope for breast cancer therapy?
-
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer
-
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDAMB-231 breast cancer cell migration
-
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis
-
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth
-
Induction of the fatty acid 2-hydroxylase (FA2H) gene by â9-tetrahydrocannabinol in human breast cancer cells
-
Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells
-
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers
-
The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy
-
Inhibition Of Fatty Acid Amide Hydrolase Activates Nrf2 Signaling And Induces Heme Oxygenase 1 Transcription In Breast Cancer Cells
-
CB1 and CB2 Receptors are Novel Molecular Targets for Tamoxifen and 4OHTamoxifen
-
US Patent Application 20130059018 â PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER
-
Cannabinoids may be therapeutic in breast cancer
-
Role of cannabinoid and vanilloid receptors in invasion of human breast carcinoma cells
-
The effect of CBG (BDS) botanical cannabinoid extract on MCF-7 human breast carcinoma cells
-
Inflammatory signaling as a therapeutic target for the treatment of breast cancer-induced bone pain
-
Differential Modulation of Tumor Cell Proliferation and their Endocannabinoid System by Polyunsaturated Fatty Acids
-
Magnolol induces apoptosis in MCF-7 human breast cancer cells through G2/M phase arrest and caspase-independent pathway
-
Anandamide inhibits breast tumor-induced angiogenesis
-
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells
-
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
-
Magnolia dealbata seeds extract exert cytotoxic and chemopreventive effects on MDA-MB231 breast cancer cells
-
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
-
Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer induced osteolysis
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
-
Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against TripleNegative Breast Cancer
-
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer
-
Curcumin sensitizes human U-87 glioblastoma and MCF-7 breast cancer cells to the endocannabinoid reuptake inhibitor OMDM-2
-
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development
-
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent
-
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer
-
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
-
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
-
Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer
-
Delineating the molecular mechanisms of tamoxifenâs oncolytic actions in estrogen receptor-negative cancers
-
Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness
-
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
CANCER-CERVICAL (5)
-
Marijuana Use is Not Associated with Cervical Human Papillomavirus Natural History or Cervical Neoplasia in HIV-Seropositive or HIV-Seronegative Women
-
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
-
The evolving role of the endocannabinoid system in gynaecological cancer
-
Over-expression of cannabinoid receptor 2 induces the apoptosis of cervical carcinoma Caski cells
-
Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
CANCER-CHOLANGIOCARCINOMA (6)
-
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling
-
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases
-
Recent advances in the regulation of cholangiocarcinoma growth
-
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: antiinvasion activity at low concentration and apoptosis induction at high concentration
-
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
-
The novel cannabinoid receptor GPR55, inhibits cholangiocarcinoma growth
CANCER-COLON/COLORECTAL (40)
-
Effects of anandamide on polyamine levels and cell growth in human colon cancer cells
-
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids or the treatment of inflammatory diseases
-
Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability
-
The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells
-
Induction of p53-independent apoptosis by a novel synthetic hexahydrocannabinol analog is mediated via Sp1-dependent NSAID-activated gene-1 in colon cancer cells
-
Involvement of NSAID-activated gene-1 in a novel synthetic hexahydrocannabinol analogue-induced growth inhibition and apoptosis of colon cancer cells
-
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
-
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent
-
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects
-
Phytocannabinoids for use in the treatment of cancer â Patent GB2478595 (A) â 2011-09-14
-
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth
-
Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts
-
Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxiainducible factor-1α activation
-
The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model
-
Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells
-
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
-
O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms
-
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer
-
The Cannabinoid WIN 55,212-2 Decreases Specificity Protein (Sp) Transcription Factors and the Oncogenic Cap Protein eIF4E in Colon Cancer Cells
-
Honokiol as a Radiosensitizing Agent for Colorectal cancers
-
US Patent Application 20130059018 â PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER
-
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
-
Stabilization of MDA-7/IL-24 for colon cancer therapy
-
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis derived non-psychotropic cannabinoid
-
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells
-
Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol
-
WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation
-
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Î9-tetrahydrocannabinol pharmacology
-
Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population
-
Extravirgin olive oil up-regulates CB1 tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms
-
Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines
-
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer
-
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease
-
CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
-
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
-
Endocannabinoids in the gut
-
The gastrointestinal tract â a central organ of cannabinoid signaling in health and disease
-
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23âIL-17 signalling in macrophages
CANCER-ENDOMETRIAL (4)
-
The Levels of the Endocannabinoid Receptor CB2 and Its Ligand 2-Arachidonoylglycerol Are Elevated in Endometrial Carcinoma
-
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers
-
Effect of anandamide on endometrial adenocarcinoma (Ishikawa) cell numbers: implications for endometrial cancer therapy
-
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
CANCER-GASTRIC (8)
-
Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and c onsequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals
-
Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells
-
Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells
-
Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells
-
Antineoplastic Effect of WIN 55,212-2, a Cannabinoid Agonist, in a Murine Xenograft Model of Gastric Cancer
-
Simulation of Swansonâs Literature-Based Discovery: Anandamide Treatment Inhibits Growth of Gastric Cancer Cells In Vitro and In Silico
-
WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals
-
Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells
CANCER-GLIOMA/BRAIN CANCERS (45)
-
Cannabidiol Enhances the Inhibitory Effects of Î9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
-
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas
-
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress
-
Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas
-
Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and AntiInflammatory Agents
-
Anti-tumoural effects of cannabinoid combinations â Patent TW201002315 (A) â2010-01-16
-
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas
-
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible role of Cannabis inhalation
-
A combined preclinical therapy of cannabinoids and temozolomide against glioma
-
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action
-
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model
-
Phytocannabinoids for use in the treatment of cancer â Patent GB2478595 (A) â 2011-09-14
-
Cannabidiol inhibits angiogenesis by multiple mechanisms
-
Alteration of endocannabinoid system in human gliomas
-
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
-
Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233
-
The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients
-
Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
-
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme
-
Influence of serum and albumin on the in vitro anandamide cytotoxicity toward C6 glioma cells assessed by the MTT cell viability assay: implications for the methodology of the MTT tests
-
Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells
-
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
-
Cannabinoid signaling in glioma cells
-
Regulation of cell proliferation by GPR55/cannabinoid receptors using (R,Râ)-4â-methoxy-1-naphthylfenoterol in rat C6 glioma cell line
-
Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas
-
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood Brain Barrier
-
The antitumor action of cannabinoids on glioma tumorigenesis
-
The Combination of Cannabidiol and Î9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model
-
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies
-
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patientsâ cells
-
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
-
Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stemlike cells proliferation by inducing autophagy in a TRPV2-dependent manner
-
On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines
-
Co-mutated pathways analysis highlights the coordination mechanism in glioblastoma multiforme
-
Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells
-
Curcumin sensitizes human U-87 glioblastoma and MCF-7 breast cancer cells to the endocannabinoid reuptake inhibitor OMDM-2
-
Endocannabinoid system as a regulator of tumor cell malignancy â biological pathways and clinical significance
-
Influence of Biomechanical Properties and Cannabinoids on Tumor Invasion
-
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system
-
Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability o glioblastoma and neural progenitor cells in culture
-
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (2016
CANCER-HEAD AND NECK (10)
-
Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium
-
The use of cannabinoids in chronic pain
-
The use of cannabinoids in chronic pain
-
Cannabis and the Lung: No More Smoking Gun?
-
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck
-
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species
-
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patientsâ survival
-
Head and neck cancer among marijuana users: A meta-analysis of matched case-control studies
-
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanineinduced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells
-
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy
CANCER-KIDNEY (6)
-
Cannabinoid CB1 Receptor Is Downregulated in Clear Cell Renal Cell Carcinoma
-
Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells
-
Cannabinoid CB(1) receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma
-
Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics
-
The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory
-
Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression
CANCER-LEUKEMIA (13)
-
Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS)
-
Cannabidiol induced a contrasting pro-apoptotic effect between freshly isolated and precultured human monocytes
-
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids
-
Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation
-
Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules
-
A role for oleoylethanolamide in chronic lymphocytic leukemia
-
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells.
-
Effect of Honokiol on Proliferation and Apoptosis in HL-60 Cells and Its Potential Mechanism
-
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
-
Downstream effects of endocannabinoid on blood cells: implications for health and disease
-
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
-
Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation
-
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies?
CANCER-LIVER (19)
-
The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis
-
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases
-
The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells
-
Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells
-
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK dependent activation of autophagy
-
Cannabinoid receptor activation correlates with the pro-apoptotic action of the β2-adrenergic agonist, (R,Râ)-4-methoxy-1-naphthylfenoterol, in HepG2 hepatocarcinoma cells
-
Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells
-
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry
-
Evaluation of Anti-invasion Effect of Cannabinoids on Human Hepatocarcinoma Cells
-
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma
-
(R,Râ)-4â-methoxy-1-naphthylfenoterol Inhibits GPR55 signaling and the modulation of motility in human cancer cells
-
(R,Râ)-4â²-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs Cancer Cell Motility
-
PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells
-
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells
-
[Corrigendum] Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells
-
Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells
-
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis
-
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis
-
Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human SMMC-7721 hepatocellular carcinoma cells
CANCER-LUNG (32)
-
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
-
Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells
-
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
-
Effects of smoking cannabis on lung function
-
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis
-
PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis
-
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
-
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years
-
Anti-proliferative and Anti-angiogenic Effects of CB2R Agonist (JWH-133) in Nonsmall Lung Cancer Cells (A549) and Human Umbilical Vein Endothelial Cells: an in Vitro Investigation
-
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
-
Effects of marijuana smoking on the lung
-
Cannabis and the Lung: No More Smoking Gun?
-
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors
-
Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells
-
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway
-
Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells
-
Cannabinoids Increase Lung Cancer Cell Lysis By Lymphokine-Activated Killer Cells Via Upregulation of ICAM-1
-
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
How beneficial is vaping cannabis to respiratory health compared to smoking?
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
-
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4
-
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells
-
Endocannabinoid system as a regulator of tumor cell malignancy â biological pathways and clinical significance
-
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells
-
Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway
CANCER-LYMPHOMA (11)
-
WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells
-
The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas
-
The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical outcome in diffuse large B-cell lymphomas
-
Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism
-
Expression and functional relevance of cannabinoid receptor 1 in hodgkin lymphoma
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features
-
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features
-
Influence of rimonabant treatment on peripheral blood mononuclear cells flow cytometry analysis and gene expression profiling
-
The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma
-
High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana
CANCER-MELANOMA (16)
-
The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft
-
Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect
-
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
-
Revisiting CB1 Receptor as Drug Target in Human Melanoma
-
Cannabinoid receptor 2 is upregulated in melanoma
-
Anticancer activity of anandamide in human cutaneous melanoma cells
-
Calcium regulation by temperature-sensitive transient receptor potential channels in human uveal melanoma cells
-
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
-
Docosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target?
-
Honokiol inhibits melanoma stem cells by targeting notch signaling
-
Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway
-
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death
-
Differential role of cannabinoids in the pathogenesis of skin cancer
-
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells
-
Melanoma research in Hungary: promising results in a previously orphan tumor
-
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells
CANCER-MULTIPLE MYELOMA (7)
-
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy induced painful neuropathy
-
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2
-
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption
-
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
-
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
-
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies?
-
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
CANCER-NASOPHARYNGEAL (1)
CANCER-NEUROBLASTOMA (10)
-
Cancer â Childhood neuroblastoma complete remission
-
Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism
-
Dual inhibition of MAGL and type II topoisomerase by N-phenylmaleimides as a potential strategy to reduce neuroblastoma cell growth
-
â(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells
-
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CBâ- and FAAH-independent mechanisms
-
AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells
-
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells
-
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma
-
JWH-133, a Selective Cannabinoid CB2 Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells
-
Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines
CANCER-ORAL (7)
-
Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells
-
Cannabinoids attenuate cancer pain and proliferation in a mouse model
-
Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells
-
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges
-
Anti-proliferative effect of honokiol in oral squamous cancer through the regulation of specificity protein 1
-
Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium
-
Review of Various Herbal Supplements as Complementary Treatments for Oral Cancer
CANCER-OVARIAN (6)
-
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
-
Dronabinol Treatment of Refractory Nausea and Vomiting Related to Peritoneal Carcinomatosis
-
Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors
-
The G-protein coupled receptor 55-agonist L-α-lysophosphatidylinositol mediates ovarian carcinoma cell induced angiogenesis
-
The evolving role of the endocannabinoid system in gynaecological cancer
-
Why I chose to use cannabis
CANCER-PANCREATIC (6)
-
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
-
Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells
-
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells
-
(R,Râ)-4â²-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs Cancer Cell Motility
-
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
CANCER-PROSTATE (36)
-
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
-
The endocannabinoid system and cancer: therapeutic implication
-
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent
-
Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells
-
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
-
Phytocannabinoids for use in the treatment of cancer â Patent GB2478595 (A) â2011-09-14
-
The endocannabinoid system in prostate cancer
-
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines
-
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
-
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells
-
Towards the use of non-psychoactive cannabinoids for prostate cancer
-
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series
-
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth
-
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth
-
Tumour epithelial expression levels of endocannabinoid markers modulates the value of endoglin-positive vascular density as a prognostic marker in prostate cancer
-
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: proapoptotic effects and underlying mechanisms
-
Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer
-
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers
-
US Patent Application 20130059018 â PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER
-
Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity
-
The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells
-
Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations
-
Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray
-
Honokiol inhibits androgen receptor activity in prostate cancer cells
-
Cannabinoids as therapeutic agents in cancer: current status and future implications.
-
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
-
Proapoptotic effect of endocannabinoids in prostate cancer cells
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Cannabinoid Receptorâ2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and PâSelectin Activity.
-
Co-Localization of Alpha1-Adrenoceptors and GPR55: A Novel Prostate Cancer Paradigm?
-
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
-
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer
-
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
-
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells
-
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
-
A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells
CANCER-SKIN (10)
-
Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation
-
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
-
Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments
-
Cyclooxygenase-2 regulates anandamide-induced endoplasmic reticulum stress in tumorigenic keratinocytes
-
Structure-dependent inhibitory effects of synthetic cannabinoids against 12-Otetradecanoylphorbol-13-acetate-induced inflammation and skin tumour promotion in mice
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
The effect of CBD, CBG and a combination of CBD plus CBG on Haccat human skin carcinoma cells
-
Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides
-
Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling
-
The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation
CANCER-SQUAMOUS CELL CARCINOMA (12)
-
Expression of cannabinoid receptor 2 in squamous cell carcinoma
-
Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells
-
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges
-
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck
-
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species
-
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
-
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patientsâ survival
-
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanineinduced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells
-
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells
-
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy
-
Medical Cannabis in the Palliation of Malignant WoundsâA Case Report
-
Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis
CANCER-VARIOUS/UNNAMED (136)
-
Antitumorigenic Effects of Cannabinoids beyond Apoptosis
-
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain
-
NEW USE FOR CANNABINOID-CONTAINING PLANT EXTRACTS Patent application number: 20100249223
-
US Patent Application 20100204312 â METHODS AND COMPOSITIONS FOR TREATING CANCER
-
Targeting the Endocannabinoid System for the Treatment of Cancer â A Practical View
-
Cannabis-derived substances in cancer therapyâan emerging anti-inflammatory role for the cannabinoids
-
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade
-
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
-
Intrathecal Administration of the Cannabinoid 2 Receptor Agonist JWH015 Can Attenuate Cancer Pain and Decrease mRNA Expression of the 2B Subunit of N-Methyld-Aspartic Acid
-
The endocannabinoid system and cancer: therapeutic implication
-
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
-
The intersection between cannabis and cancer in the United States
-
Phytocannabinoids for use in the treatment of cancer â Patent GB2478595 (A) â 2011-09-14
-
Update on the endocannabinoid system as an anticancer target
-
The endocannabinoid system in the cancer therapy: an overview
-
Cannabidiol inhibits angiogenesis by multiple mechanisms
-
Cannabinoid-associated cell death mechanisms in tumor models (Review)
-
Monoacylglycerol lipase â a target for drug development?
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth
-
Role of Lipid Rafts/Caveolae in the Anticancer Effect of Endocannabinoids
-
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
-
The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world
-
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy
-
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
-
Towards the use of cannabinoids as antitumour agents
-
Modulating the endocannabinoid system in human health and disease: successes and failures
-
Autophagy triggered by magnolol derivative negatively regulates angiogenesis
-
Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesis
-
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
-
The endocannabinoid system, cannabinoids, and pain
-
An open-label extension study to investigate the long-term safety and tolerability of THC / CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics
-
A potential role for GPR55 in gastrointestinal functions
-
Therapeutic potential of monoacylglycerol lipase inhibitors
-
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers
-
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management
-
Cannabidiol as potential anticancer drug
-
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
-
Critical appraisal of the potential use of cannabinoids in cancer management
-
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors
-
Therapeutic potential of cannabinoid medicines
-
Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells
-
The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action
-
The endocannabinoid signaling system in cancer
-
Cytotoxic effect of Efavirenz is selective against cancer cells and associated with the cannabinoid system
-
Preparation and characterization of Î9-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines
-
Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1
-
Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis
-
Medical marijuana for cancer
-
Marijuana and Body Weight
-
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders
-
Clinical evaluation and optimal management of cancer cachexia
-
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
-
Target-Selective Phototherapy Using a Ligand-Based Photosensitizer for Type 2 Cannabinoid Receptor
-
The Neurobiology of Cancer Pain
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β
-
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases
-
Report on Medical Cannabis Research History- What the Science Says
-
Is the Clinical Use of Cannabis by Oncology Patients Advisable?
-
The Role of Monoacylglycerol Lipase (MAGL) in the Cancer Progress
-
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases
-
Cannabinoid CB2 Receptor as a New Phototherapy Target for Inhibition of Tumor Growth
-
Characterization of HU-331 as a cannabinoid quinone inhibitor of topoisomerase II
-
AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells
-
Use and medicalization of marihuana in cancer patients
-
The Neurobiology of Cancer Pain
-
Cannabis in cancer care
-
The use of cannabinoids as anticancer agents
-
Cannabis and Cannabinodsâfor health professionals (PDQ®)
-
Cannabis and Cannabinoids (PDQ®): Patient Version
-
PROGRESS REPORT Compassionate Use of Medical Cannabis Pilot Program Act July 1, 2014 through June 30, 2015
-
Plant derived substances with anti-cancer activity: from folklore to practice
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
-
The evolving role of the endocannabinoid system in gynaecological cancer
-
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience
-
Î9 Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8
-
Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo
-
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science
-
New insights into antimetastatic and antiangiogenic effects of cannabinoids
-
Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides
-
Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice
-
Downstream effects of endocannabinoid on blood cells: implications for health and disease
-
Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects
-
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer
-
A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients
-
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
-
Endocannabinoids and Cancer
-
Oncosuppressive functions of tribbles pseudokinase 3
-
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats
-
Cannabinoid-induced autophagy: protective or death role?
-
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
-
Delta(9)-tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature
-
Cannabis and cancer: reality or pipe dream?
-
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveal a Mechanism for Regulation of Tumor Progression
-
Natural product modulators of transient receptor potential (TRP) channels as potential anti-cancer agents
-
Endocannabinoids as Guardians of Metastasis
-
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells
-
Cannabis and cancer: toward a new understanding
-
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
-
Integrating cannabis into clinical cancer care
-
Anticancer mechanisms of cannabinoids
-
Endocannabinoid system as a regulator of tumor cell malignancy â biological pathways and clinical significance
-
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
-
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
-
A userâs guide to cannabinoid therapies in oncology
-
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
-
Cannabis and Cannabinoids (PDQ®)Health Professional Version
-
Using Medical Cannabis in an Oncology Practice
-
Using Medical Cannabis in an Oncology Practice
-
Cannabis and Cannabinoids
-
Ligands for cannabinoid receptors, promising anticancer agents
-
Role of the lysophosphatidylinositol/GPR55 axis in cancer
-
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome
-
Antitumorigenic targets of cannabinoids â current status and implications
-
Delineating the molecular mechanisms of tamoxifenâs oncolytic actions in estrogen receptor-negative cancers
-
Influence of Biomechanical Properties and Cannabinoids on Tumor Invasion
-
The Use of Medical Marijuana in Cancer
-
Phytochemicals as adjunctive with conventional anticancer therapies
-
Pediatric oncology providers and use of medical marijuana in children with cancer
-
Endocannabionoid System in Neurological Disorders
-
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence
-
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation
-
N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation
-
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review)
-
Bioactive spirans and other constituents from the leaves of Cannabis sativa f. sativa
-
State of the evidence: Cannabinoids and cancer pain-A systematic review
-
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion
-
Cannabinoids â a new weapon against cancer?
-
Medical Cannabis in the Palliation of Malignant WoundsâA Case Report
-
Expertsâ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study.
CANCERâTESTICULAR (1)
CANNABINOID HYPEREMESIS SYNDROME (62)
-
Cannabinoid hyperemesis. (# 1)
-
Cannabinoid Hyperemesis and Compulsive Bathing: A Case Series and Paradoxical Pathophysiological Explanation
-
Cannabinoid-Induced Hyperemesis: A ConundrumâFrom Clinical Recognition to Basic Science Mechanisms
-
The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States
-
A man in his 30s with recurrent vomiting and abdominal pain relieved by hot showers
-
Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting
-
Cannabis Hyperemesis Syndrome (# 1)
-
Cannabis Hyperemesis Syndrome (# 2)
-
Image of the month. Skin discoloration from compulsive bathing in a patient with hyperemesis syndrome
-
Cannabis Hyperemesis Syndrome (# 3)
-
Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance
-
Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm
-
Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy
-
Pediatric cannabinoid hyperemesis: two cases
-
Hyperemesis and a High Water Bill
-
Cannabinoid hyperemesis syndrome: case report of a paradoxical reaction with heavy marijuana use
-
Cannabinoid hyperemesis: a case series of 98 patients
-
Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males
-
CannabisâA Valuable Drug That Deserves Better Treatment
-
Association of Marijuana Use and Cyclic Vomiting Syndrome
-
Cannabinoid hyperemesis. (# 4)
-
A hot bath to calm what ails you â the Cannabis Hyperemesis Syndrome
-
Cannabinoid Hyperemesis Syndrome: A Case Series and Review of Previous Reports
-
Spicing Up the Differential for Cyclic Vomiting: A Case of Synthetic-Cannabinoid Induced Hyperemesis Syndrome (CH)
-
Cannabinoid Hyperemesis Syndrome
-
Compulsive showering and marijuana use â the cannabis hyperemisis syndrome
-
Cannabinoid Hyper-emesis Syndrome: An Enigma
-
Cannabinoid hyperemesis syndrome with extreme hydrophilia
-
A Case of Cannabinoid Hyperemesis Syndrome Caused by Synthetic Cannabinoids
-
Haloperidol for treatment of cannabinoid hyperemesis syndrome
-
Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid hyperemesis syndrome
-
A Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid
-
Mid-ventricular Variant Takotsubo Cardiomyopathy Associated with Cannabinoid Hyperemesis Syndrome: A Case Report
-
Cannabinoid hyperemesis should be recognised as an effect of chronic cannabis abuse
-
Case of cannabinoid hyperemesis syndrome with long-term follow-up
-
Cannabinoid Hyperemesis Syndrome: A Case Report and Review of Pathophysiology
-
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS)
-
Cannabinoid Hyperemesis Syndrome: An Emerging Drug-Induced Disease
-
No opiates against cannabis hyperemesis syndrome
-
Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome
-
Cannabinoid hyperemesis syndrome: About 6 cases
-
Cyclic Vomiting Presentations Following Marijuana Liberalization in Colorado
-
Cannabinoid Hyperemesis Syndrome: Descriptive Overview of an Under-Recognized Diagnosis
-
Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic
-
Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect
-
13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire
-
A non-classical cannabinoid syndrome
-
Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review
-
Novel case of synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure
-
Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury
-
Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting
-
Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting
-
Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use
-
An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of Jejunum on the Way to Unravel Her Hyperemesis Enigma
-
Cannabinoid hyperemesis syndrome masquerading as an eating disorder
-
Cannabinoid hyperemesis syndrome and the onset of a manic episode
-
Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study
-
Hypophosphatemia in Users of Cannabis
-
Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline.
-
Role of cannabis in digestive disorders
-
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review
-
Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
CARPAL TUNNEL SYNDROME (2)
CATATONIA (4)
-
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report
-
Could spice drugs induce psychosis with abnormal movements similar to catatonia?
-
Catatonia and Cannabis Withdrawal: a case report
-
Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis
CELIAC DISEASE (3)
CEREBRAL PALSY (1)
CHEMICAL COMPOSITION (114)
-
Cannabinoid and Terpenoid Reference Guide
-
Î9-Tetrahydrocannabinol content in cannabis samples seized in Novi Sad during 2008
-
In silicio expression analysis of PKS genes isolated from Cannabis sativa L
-
QUALITY OF HEMP SEED OIL DEPENDING ON ITS OBTAINING
-
Stable isotope models to predict geographic origin and cultivation conditions of marijuana
-
Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes
-
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers
-
The results of an experimental indoor hydroponic Cannabis growing study, using the âScreen of Greenâ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis
-
Variation in Î9-THC and other Cannabinoids Content in Field Grown Cannabis sativa L During Different Stages of Growth
-
Cannabis as a Unique Functional Food
-
How Accurate is Potency Testing?
-
Changes of photosynthesis-related parameters and productivity of Cannabis sativa under different nitrogen supply
-
Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp (Cannabis sativa L)
-
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail
-
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
-
Heterogeneity in the composition of marijuana seized in California
-
How hemp got high
-
Isolation and Characterization of Edestin from Cheungsam Hempseed
-
Characteristics of cannabinoids composition of Cannabis plants grown in Northern Thailand and its forensic application
-
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
-
Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa)
-
Cadmium Tolerance and Bioaccumulation of 18 Hemp Accessions
-
Cannabinoids: occurrence and medicinal chemistry
-
Cannabis profiling based on its elemental compositionâis it possible?
-
Variations in Photosynthesis, Transpiration, Water Use and Cannabinoid Contents in Field Grown Drug Type Varieties of Cannabis sativa L.
-
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L. under Slow Growth Conditions
-
Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides
-
Isolation and characterization of some phytochemicals from Indian traditional plants
-
The hexanoyl-CoA precursor for cannabinoid biosynthesis is formed by an acylactivating enzyme in Cannabis sativa trichomes
-
Terpenoid biosynthesis in trichomesâcurrent status and future opportunities
-
Hemp Biology â Industrial Hemp vs. Marijuana
-
Hemp Species
-
Cannabis Strains: Do Cannabis Strains Differ?
-
Cannabis Genome Uncloaked: Commentary on the Scientific Implications
-
Cannabis Genome Uncloaked: Commentary on the Scientific Implications
-
Is todayâs marijuana more potent simply because itâs fresher?
-
Proteomic profiling of hempseed proteins from Cheungsam
-
Cannabis â from cultivar to chemovar
-
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects
-
Chemiluminescence detection of cannabinoids and related compounds with acidic potassium permanganate
-
Structure and Function of Î1-Tetrahydrocannabinolic Acid (THCA) Synthase, the Enzyme Controlling the Psychoactivity of Cannabis sativa
-
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR
-
Studies on the Optimization of Agrotechniques to Maximize the Productivity of Two Cannabis Chemotypes Cultivated to Produce Medicinal Grade Plant Material
-
Cannabis, a complex plant: different compounds and different effects on individuals
-
In planta imaging of Î9-tetrahydrocannabinolic acid in Cannabis sativa L. with hyperspectral coherent anti-Stokes Raman scattering microscopy
-
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
-
Early Phenylpropanoid Biosynthetic Steps in Cannabis sativa: Link between Genes and Metabolites
-
Chemical profiling of different hashish seizures by gas chromatography-mass spectrometry and statistical methodology: a case report
-
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants
-
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
-
Biotransformation of cannabinoids by a cell suspension culture of Cannabis sativa L
-
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK
-
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures
-
Ethephon application stimulates cannabinoids and plastidic terpenoids production in Cannabis sativa at flowering stage
-
Study of leaf metabolome modifications induced by UV-C radiations in representative Vitis, Cissus and Cannabis species by LC-MS based metabolomics and antioxidant assays
-
Affinity comparison of different THCA synthase to CBGA using modeling computational approaches
-
Influence of mevinolin on chloroplast terpenoids in Cannabis sativa
-
Targeted mutation of Î12 and Î15 desaturase genes in hemp produce major alterations in seed fatty acid composition including a high oleic hemp oil
-
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
-
Amber is Bad ?
-
Variability of cannabis potency in the Venice area (Italy): A survey over the period 2010- 2012
-
Hemp (Cannabis sativa L.) seed oil: Analytical and phytochemical characterization of unsaponifiable fraction
-
Metals and organic compounds in the biosynthesis of cannabinoids: a chemometric approach to the analysis of Cannabis sativa samples
-
A PCR marker Linked to a THCA synthase Polymorphism is a Reliable Tool to Discriminate Potentially THC-Rich Plants of Cannabis sativa L.
-
Molecular characterization of edestin gene family in Cannabis sativa L.
-
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content
-
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users
-
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia
-
Minor oxygenated cannabinoids from high potency Cannabis sativa L
-
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
-
Cannabinoids Production by Hairy Root Cultures of Cannabis sativa L
-
Seized cannabis seeds cultivated in greenhouse: A chemical study by gas chromatographyâmass spectrometry and chemometric analysis
-
Method for the Analysis of Cannabinoids and Terpenes in Cannabis
-
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype
-
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L
-
Evaluation of elemental profiling methods, including laser-induced breakdown spectroscopy (LIBS), for the differentiation of Cannabis plant material grown in different nutrient solutions
-
(1)H NMR and HPLC/DAD for Cannabis sativa L chemotype distinction, extract profiling and specification
-
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users
-
Determination of the relative percentage distribution of THCA and Î9-THC in herbal cannabis seized in Austria â Impact of different storage temperatures on stability
-
Cannabis and Endocannabinoid Signaling in Epilepsy
-
Expression, purification and crystallization of a plant polyketide cyclase from Cannabis sativa
-
Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using High-Performance Liquid Chromatography
-
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users
-
Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana)
-
Biotransformation of Tetrahydrocannabinol
-
Evolution and Classification of Cannabis sativa (Marijuana, Hemp) in Relation to Human Utilization
-
Expansion of female sex organs in response to prolonged virginity in Cannabis sativa (marijuana)
-
Cannabinoids for pediatric epilepsy? Up in smoke or real science?
-
Harvesting the biosynthetic machineries that cultivate a variety of indispensable plant natural products
-
Cannabis sativa: The Plant of the Thousand and One Molecules
-
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
-
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes
-
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
-
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis
-
A Belated Green Revolution for Cannabis: Virtual Genetic Resources to Fast-Track Cultivar Development
-
Analysis of a commerical marijuana e-cigarette formulation
-
Structural basis for olivetolic acid formation by a polyketide cyclase from Cannabis sativa
-
Changes in cannabis potency over the last two decades (1995-2014 â Analysis of current data in the United States
-
Chapter 2 â Biosynthesis and Pharmacology of Phytocannabinoids and Related Chemical Constituents
-
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes
-
The influences of cultivation setting on inflorescence lipid distributions, concentrations, and carbon isotope ratios of Cannabis sp.
-
In Vitro Propagation of Cannabis sativa L. and Evaluation of Regenerated Plants for Genetic Fidelity and Cannabinoids Content for Quality Assurance
-
Monitoring Metabolite Profiles of Cannabis sativa L. Trichomes during Flowering Period Using 1H NMR-Based Metabolomics and Real-Time PCR
-
Seed composition of ten industrial hemp cultivars approved for production in Canada
-
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks
-
Near infrared spectroscopy combined with chemometrics for growth stage classification of cannabis cultivated in a greenhouse from seized seeds
-
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy
-
Bioactive spirans and other constituents from the leaves of Cannabis sativa f. sativa
-
Marijuana vs. Hemp: Whatâs the Difference?
-
Transcriptome differences between fiber-type and seed-type Cannabis sativa variety exposed to salinity
-
A study of cannabis potency in France over a 25 years period (1992-2016
-
Quality Control of Traditional Cannabis Tinctures: Pattern, Markers, and Stability
-
Broad-Scale Genetic Diversity of Cannabis for Forensic Applications
-
Phytochemistry of Cannabis sativa L.
CHEMOTHERAPY (71)
-
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy
-
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting
-
Mechanisms of Broad-Spectemetic Efficacy of Cannabinoids against Chemotherapy Induced Acute and Delayed Vomiting
-
Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice
-
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative / Nitrosative Stress, Inflammation, and Cell Death
-
Regulation of nausea and vomiting by cannabinoids
-
Medical cannabis: the opportunity versus the temptation
-
Biotechnology of Cannabis sativa L.
-
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy
-
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy
-
β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner
-
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series
-
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment
-
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System
-
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting
-
Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats
-
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2
-
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain
-
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
-
Characterisation of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy
-
Additive antiemetic efficacy of 9-THC with vanilloid TRPV1 receptor agonists in the least shrew (Cryptotis parva)
-
Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity
-
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Î9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva)
-
Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid
-
Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-targeted prevention of paclitaxel-induced neuropathy
-
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
-
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases
-
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery
-
Medical marijuana for cancer
-
Medical marijuana: more questions than answers
-
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy
-
Activation of G-protein-coupled receptor 40 attenuates the cisplatin-induced apoptosis of human renal proximal tubule epithelial cells
-
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal
-
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy
-
Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting
-
HU-331 Is a Catalytic Inhibitor of Topoisomerase Iiα
-
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review
-
Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis
-
Coadministration of indomethacin and minocycline attenuates established paclitaxel induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors
-
Cannabis and Cannabinoidsâfor health professionals (PDQ®)
-
Cannabis and Cannabinoids (PDQ®): Patient Version
-
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience
-
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain
-
Medical Marijuana: Is the Cart Before the Horse?
-
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
-
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science
-
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives
-
Peroxisome Proliferator-Activated Receptor-α Inhibition Protects Against Doxorubicin Induced Cardiotoxicity in Mice
-
Controlled release tablet formulation containing natural δ9 tetrahydrocannabinol
-
Endocannabinoid Mechanisms Influencing Nausea
-
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer
-
Cannabis and cancer: toward a new understanding
-
Integrating cannabis into clinical cancer care
-
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
-
Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment
-
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
-
Why I chose to use cannabis
-
Using Medical Cannabis in an Oncology Practice
-
Using Medical Cannabis in an Oncology Practice
-
Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex interferes with anticipatory nausea in a rat model
-
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice
-
Phytochemicals as adjunctive with conventional anticancer therapies
-
Pediatric oncology providers and use of medical marijuana in children with cancer
-
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence
-
Effect of combined oral doses of Î9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models
-
May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat
-
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
-
Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture
-
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma
CHILDREN (79)
-
Endocannabinoid (EC) Receptor, CB1, and EC Enzymesâ Expression in Primary Adipocyte Cultures of Lean and Obese Pre-pubertal Children in Relation to Adiponectin and Insulin
-
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics
-
A short-term, quasi-experimental evaluation of D.A.R.E.âs revised elementary school curriculum
-
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
-
Examining the Health and Drug Exposures among Canadian Children Residing in Drug Producing Homes
-
Early exposure to Environmental enrichment alters the expression of genes of the endocannabinoid system
-
Accidental cannabis poisoning in children: report of four cases in a tertiary care center from southern Spain
-
Pediatric cannabinoid hyperemesis: two cases
-
Cannabinoids in children
-
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease
-
Intelligence quotient in childhood and the risk of illegal drug use in middle-age: the 1958 National Child Development Survey
-
Childhood Obesity and the Role of Dopamine D2 Receptor and Cannabinoid Receptor-1 Gene Polymorphisms
-
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment resistant epilepsy
-
The role of child protection in cannabis grow-operations
-
The role of child protection in cannabis grow-operations
-
Anticipated Medical Effects on Children From Legalization of Marijuana in Colorado and Washington State
-
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt
-
Methadone and illegal drugs in hair from children with parents in maintenance treatment or suspected for drug abuse in a German community
-
The case for medical marijuana in epilepsy
-
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury
-
Pediatric exposure to drugs of abuse by hair testing: monitoring 15 years of evolution in Spain
-
The consequences of pain in early life: injury-induced plasticity in developing pain pathways
-
Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students
-
Cannabinoid findings in children hair â what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Î9-tetrahydrocannabinolic acid A concentrations
-
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases
-
EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM
-
Intoxication from accidental ingestion of hashish: Analysis of eight cases
-
Medical marijuana and children
-
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM
-
RESOLUTION OF SEIZURES AND NORMALIZATION OF EEG AFTER INITIATION OF CBD IN A PATIENT WITH DOOSE SYNDROME
-
The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche
-
Medical marijuanaâs public health lessonsâimplications for retail marijuana in Colorado
-
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice
-
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice
-
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
-
Association between paracetamol use in infancy or childhood with body mass index
-
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis
-
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
-
Urinary early kidney injury molecules in children with beta-thalassemia major
-
Urinary early kidney injury molecules in children with beta-thalassemia major
-
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
-
The maternal deprivation animal model revisited
-
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
-
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome
-
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis
-
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children
-
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes
-
Cannabidiol as potential treatment in refractory pediatric epilepsy
-
The Pharmacological Basis of Cannabis Therapy for Epilepsy
-
Cannabinoids for pediatric epilepsy? Up in smoke or real science?
-
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome
-
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience
-
Medicinal Use of Marijuana: What School Nurses Need to Know
-
Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders
-
Is the medical use of cannabis a therapeutic option for children?
-
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species
-
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood
-
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder
-
Î9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
-
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation
-
Detecting biomarkers of secondhand marijuana smoke in young children
-
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system
-
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
-
Childhood Maltreatment in the Migraine Patient
-
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013
-
Cannabinoid Poisoning by Hemp Seed Oil in a Child
-
Marijuana Misadventures in Children: Exploration of a Dose-Response Relationship and Summary of Clinical Effects and Outcomes
-
Pediatric oncology providers and use of medical marijuana in children with cancer
-
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
-
Childhood weight status and timing of first substance use in an ethnically diverse sample
-
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
-
Disturbances of sleep and circadian rhythms: novel risk factors for obesity
-
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system
-
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use
-
Child maltreatment and cannabis use in young adulthood: A birth cohort study
-
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease
-
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma
-
Using Medical Marijuana to Stop Childhood Seizures
-
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults
CHOLESTEROL (48)
-
A common CNR1 (cannabinoid receptor 1) haplotype attenuates the decrease in HDL cholesterol that typically accompanies weight gain
-
A randomised, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GW42003 : GW42004 plus GW42003 and GW42004 alone in the treatment of dyslipidaemia in subjects with Type 2 diabetes
-
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population
-
The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia
-
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor
-
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance
-
The Non-Psychoactive Plant Cannabinoid, Cannabidiol Affects Cholesterol Metabolism-Related Genes in Microglial Cells
-
The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits
-
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice
-
Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice
-
Interleukin-1β causes anxiety by interacting with the endocannabinoid system
-
CNR1 genotype influences HDL-cholesterol response to change in dietary fat intake
-
Rimonabant improves obesity but not the overall cardiovascular risk and quality of life results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)
-
EFFECTS OF GRADED LEVELS OF HEMP SEED (CANNABIS SATIVA L.) ON PERFORMANCE, ORGAN WEIGHT AND SERUM CHOLESTEROL LEVELS ON BROILERS
-
Treatment with CB 2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
-
A common functional promoter variant links CNR1 gene expression to HDL cholesterol level
-
US Patent Application 20130245110 â USE FOR CANNABINOIDS (CBD/ THCV for cholesterol control)
-
GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors
-
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia
-
Role of Genetic Variation in the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) on Weight Loss and Cardiovascular Risk Factors After Liraglutide Treatment in Obese Patients With Diabetes Mellitus Type 2
-
Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients
-
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes
-
Association of polymorphisms in the endocannabinoid system genes with myocardial infarction and plasma cholesterol levels
-
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors
-
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor
-
Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH
-
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation
-
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments
-
METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS
-
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism
-
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females
-
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females
-
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression
-
Polymorphism G1359A of the cannabinoid receptor gene (CNR1): allelic frequencies and influence on cardiovascular risk factors in a multicentre study of Castilla-Leon
-
Polymorphism G1359A of the cannabinoid receptor gene (CNR1): allelic frequencies and influence on cardiovascular risk factors in a multicentre study of Castilla-Leon
-
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate
-
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate
-
Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice
-
Participation of the endocannabinoid system (ECS) in the weight-gain and sensitization to LPS exposure in a maternal obesity model
-
Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data
-
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid
-
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring
-
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid ReceptorRelated Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators
-
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens
-
Cyclooxygenase-2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells
-
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias
-
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis
-
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo Controlled, Parallel Group Pilot Study
CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS (1)
CHRONIC TRAUMATIC ENCEPHALOPATHY (2)
-
Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury
-
Correction to â Inhibition of Monoacylglycerol Lipase Prevents Chronic Traumatic Encephalopathy-Like Neuropathology in a Mouse Model of Repetitive Mild Closed Head Injury
CIDS/CNS INJURY-INDUCED IMMUNODEFICIENCY SYNDROME (3)
CIRCADIAN RHYTHM (13)
-
Regulation of the Hypothalamic-Pituitary-Adrenal Axis Circadian Rhythm by Endocannabinoids Is Sexually Diergic
-
Cannabinoids Excite Circadian Clock Neurons
-
CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice
-
Endocannabinoid signalling: has it got rhythm?
-
An endocannabinoid system is localized to the hypophysial pars tuberalis of Syrian hamsters and responds to photoperiodic changes
-
Ghrelin-mediated appetite regulation in the central nervous system
-
The emerging role of the endocannabinoid system in the sleep-wake cycle modulation
-
Does the neuroprotective role of anandamide display diurnal variations?
-
Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol
-
2-Arachidonoyl glycerol sensitizes the pars distalis and enhances forskolin-stimulated prolactin secretion in Syrian hamsters
-
The effects of chronic marijuana use on circadian entrainment
-
Disturbances of sleep and circadian rhythms: novel risk factors for obesity
-
Endocannabinoids and sleep
CNS/CENTRAL NERVOUS SYSTEM (29)
-
CannabinoidâDopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
-
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
-
The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system
-
Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice
-
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction
-
Ghrelin-mediated appetite regulation in the central nervous system
-
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling
-
Synaptic Targets of Î9-Tetrahydrocannabinol in the Central Nervous System
-
Phytocannabinoids as novel therapeutic agents in CNS disorders
-
The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System
-
Discovery of agonists of cannabinoid receptor 1 with restricted CNS penetration aimed for treatment of gastroesophageal reflux disease
-
Parsing the players: 2-AG synthesis and degradation in the CNS
-
Surinabant, a selective CB(1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans
-
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation
-
Multiple sclerosis and the blood-central nervous system barrier
-
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries
-
Involvement of nitric oxide through endocannabinoids release in microglia activation during the course of CNS regeneration in the medicinal leech
-
Gastric mucosal protection: from the periphery to the central nervous system
-
Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System
-
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders
-
Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla
-
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination
-
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processesâa Short Review
-
Phytocannabinoids and cannabimimetic drugs: recent patents in central nervous system disorders
-
Synthetic cannabinoid receptor agonists and antagonists: implication in CNS disorders.
-
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome
-
Cannabinoid receptor ligand bias: implications in the central nervous system
-
The central cannabinoid receptor type-2 (CB2) and chronic pain
-
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
COHORT/LARGE STUDIES (29)
-
Effects of cannabis on lung function: a population-based cohort study
-
Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British Cohort Study
-
Cannabis use and Cognitive Function: Eight Year Trajectory in a Young Adult Cohort
-
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts
-
Sex differences in the cumulative incidence of substance use by birth cohort
-
An ageâperiodâcohort analysis of cannabis use prevalence and frequency in Germany, 1990â2009
-
The changing demographic of blunt smokers across birth cohorts
-
Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV-Hepatitis C Coinfection: A Longitudinal Cohort Analysis
-
Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status
-
A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches
-
METABOLIC EFFECTS OF MARIJUANA USE AMONG BLACKS
-
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)
-
K2 and Spice use among a cohort of college students in southeast region of the USA
-
K2 and Spice use among a cohort of college students in southeast region of the USA
-
Who receives cannabis use offers: A general population study of adolescents
-
Association between marijuana use and adverse obstetrical and neonatal outcomes
-
Prevalence of Marijuana and Other Substance Use Before and After Washington Stateâs Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana: Cohort Comparisons in a Sample of Adolescents
-
Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users
-
Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
-
Trends in cannabis use disorders among racial/ethnic population groups in the United States
-
Cannabis Use as Risk or Protection for Type 2 Diabetes: A Longitudinal Study of 18â000 Swedish Men and Women
-
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people
-
Child maltreatment and cannabis use in young adulthood: A birth cohort study
-
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys
-
Identifying HIV care enrollees at-risk for cannabis use disorder
-
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men
-
Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse
-
Whole genome sequence study of cannabis dependence in two independent cohorts
-
Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians
COLITIS (56)
-
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohnâs Disease
-
Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis
-
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
-
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice
-
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice
-
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment
-
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
-
β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway
-
Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis
-
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases
-
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
-
The JNK inhibitor XG-102 protects against TNBS-induced colitis
-
The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model
-
Gut microbiota and the development of obesity
-
Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice
-
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
-
4-Oxo-1,4-dihydropyridines as Selective CB2 Cannabinoid Receptor Ligands Part 2: Discovery of New Agonists Endowed with Protective Effect Against Experimental Colitis
-
Role of endogenous cannabinoid system in the gut
-
O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms
-
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
-
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract
-
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis
-
Marijuana use patterns among patients with inflammatory bowel disease
-
Prostaglandin ethanolamides attenuate damage in a human explant colitis model
-
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
-
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability
-
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis
-
Cannabidiol in inflammatory bowel diseases: a brief overview
-
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model
-
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
-
The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium
-
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent
-
Medical Marijuana for Digestive Disorders: High Time to Prescribe?
-
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon Npalmitoylethanolamine levels and counteracts murine colitis
-
Switching cannabinoid response from CB2 agonists to FAAH inhibitors
-
Colitis generates remote antinociception in rats: the role of the Larginine / NO / cGMP / PKG / KATP pathway and involvement of cannabinoid and opioid systems
-
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent
-
Gastric mucosal protection: from the periphery to the central nervous system
-
GPR55 â a putative âtype 3â cannabinoid receptor in inflammation
-
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis
-
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity
-
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohnâs Disease and Ulcerative Colitis
-
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
-
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
-
Endocannabinoids in the Gut
-
The CB2 receptor and its role as a regulator of inflammation
-
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK
-
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
-
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages
-
Therapeutic Use of Cannabis in Inflammatory Bowel Disease
-
Role of cannabinoids in gastrointestinal mucosal defense and inflammation
-
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation
-
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohnâs Disease and Ulcerative Colitis
-
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease
-
Application of carbon nanotubes as the carriers of the cannabinoid, 2- arachidonoylglycerol: Towards a novel treatment strategy in colitis
-
The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis
COPD/CHRONIC OBSTRUCTIVE PULMONARY DISEASE (19)
-
Effects of cannabis on lung function: a population-based cohort study
-
Does cannabis use predispose to chronic airflow obstruction?
-
Effects of smoking cannabis on lung function
-
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety
-
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors
-
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years
-
Effects of marijuana smoking on the lung
-
Cannabis and the Lung: No More Smoking Gun?
-
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig
-
Health outcomes associated with long-term regular cannabis and tobacco smoking
-
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors
-
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury
-
Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population
-
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup
-
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough
-
Effects of Marijuana Exposure on Expiratory Airflow: A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study
-
How beneficial is vaping cannabis to respiratory health compared to smoking?
-
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs?
-
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite
COUGH (4)
-
G-protein coupled receptors regulating cough
-
Inhibition Of Fatty Acid Amide Hydrolase Produces Anti-Tussive Effects In Guinea-Pigs: Evidence For Elevated Fatty Acid Amides Acting Via Cannabinoid Receptors On Airway Sensory Nerves
-
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough
-
Endocannabinoid Inhibition Of Airway Sensory Nerve Depolarisation
CROHNâS DISEASE (37)
-
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohnâs Disease
-
Treatment of Crohnâs disease with cannabis: an observational study
-
Medical cannabis: the opportunity versus the temptation
-
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility
-
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome
-
Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome
-
Gut microbiota and the development of obesity
-
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
-
Cannabis Finds Its Way into Treatment of Crohnâs Disease
-
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract
-
Cannabis Induces a Clinical Response in Patients with Crohnâs Disease: a Prospective Placebo-Controlled Study
-
Marijuana use patterns among patients with inflammatory bowel disease
-
Marijuana use patterns among patients with inflammatory bowel disease
-
Industrial hemp decreases intestinal motility stronger than indian hemp in mice
-
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
-
Medical Marijuana for Digestive Disorders: High Time to Prescribe?
-
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases
-
Cannabis for inflammatory bowel disease
-
Colitis generates remote antinociception in rats: the role of the L-arginine/NO/cGMP/PKG/KATP pathway and involvement of cannabinoid and opioid systems
-
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohnâs disease
-
Gastric mucosal protection: from the periphery to the central nervous system
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity
-
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner
-
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat
-
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science
-
Cannabis â therapy for the future?
-
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
-
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK
-
Therapeutic Use of Cannabis in Inflammatory Bowel Disease
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review
-
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review
-
Role of cannabis in digestive disorders
-
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohnâs Disease and Ulcerative Colitis
-
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease
-
Role of cannabis in digestive disorders
CRPS/RSD-COMPLEX REGIONAL PAIN SYNDROME/REFLEX SYMPATHETIC DYSTROPHY/CAUSALGIA (2)
-
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells
-
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats
CULTIVATION (311)
-
What kind of fertilizer for hemp, at home
-
History of Hemp Cultivation in Britain
-
What Medical Marijuana strain is best for your condition, Sativa or Indica?
-
Observations on the raising and dressing of hemp (1789)
-
Observations on the raising and dressing of hemp (1789)
-
YEARBOOK OF THE UNITED STATES DEPARTMENT OF AGRICULTUREâ1913, pages 283-346
-
Influence of Environment on Sexual Expression in Hemp (1923)
-
CARBOHYDRATE-NITROGEN RATIOS WITH RESPECT TO THE SEXUAL EXPRESSION OF HEMP (1934)
-
TIME FACTOR IN UTILIZATION OF MINERAL NUTRIENTS BY HEMP by Sister Mary Etienne Tibeau (1936)
-
New Billion Dollar Crop (news â 1938)
-
New Billion Dollar Crop- Popular Mechanics (in original on page 239)
-
GROWTH RESPONSES OF HEMP TO DIFFERENTIAL SOIL AND AIR TEMPERATURES
-
Problems of modern hemp breeding, with particular reference to the breeding of varieties of hemp containing little or no hashish
-
Auxin and Sexuality in Cannabis sativa
-
Suppressive Effects of 2-thiouracil on Differentiation and Flowering in Cannabis Sativa
-
Effects of Chronic Smoking of Cannabis in Jamaica
-
Cannabinoid Profile and Elemental Uptake of Cannabis sativa L. as Influenced by Soil Characteristics
-
Cannabinoid formation in Cannabis sativa grafted inter-racially, and with two Humulus species
-
CHEMOTAXONOMY OF CANNABIS 1. CROSSBREEDING BETWEEN CANNABIS SATIVA AND C. RUDERALIS, WITH ANALYSIS OF CANNABINOID CONTENT
-
Cannabinoid composition and gland distribution in clone of Cannabis sativa L (Cannabaceae)
-
Influence of photoperiodism on cannabinoid content of Cannabis sativa L.
-
An investigation of procedures reported to increase potency of marijuana: a chemical analysis and psychological interpretation
-
The role of roots in sex expression in hemp plants
-
The influence of growth regulators absorbed by the root on sex expression in hemp plants
-
The role of leaves in sex expression in hemp and spinach
-
Sequential appearance of cannabinoids during seedling development
-
Some features of Cannabis plants grown in the United Kingdom from seeds of known origin
-
NEW FOSSIL EVIDENCE FOR THE PAST CULTIVATION AND PROCESSING OF HEMP (CANNABIS SATIVA L.) IN EASTERN ENGLAND
-
Induction of fertile male flowers in genetically female Cannabis sativa plants by silver nitrate and silver thiosulphate anionic complex
-
Marijuana, Cannabis sativa L: Moraceae, Cannaboideae
-
Structure, development and composition of glandular trichomes of Cannabis
-
Variation in vegetative growth and trichomes in Cannabis sativa L. (Marihuana) in response to enviromental pollution
-
Histochemical detection of hemp trichomes and their correlation with the THC content
-
Male and female plant selection in the cultivation of hemp, and variations in fossil Cannabis pollen representation (link to download-1992
-
Anatomy and Viability of Cannabis sativa Stem Cuttings With and Without Adventitious Roots
-
Commercial Hemp Cultivation in Canada âAn Economic Justificationâ
-
The Volatile Oil Composition of Fresh and Air-Dried Buds of Cannabis sativa
-
Cannabis pests
-
Immunochemical localization of tetrahydrocannabinol (THC) in cryofixed glandular trichomes of Cannabis (Cannabaceae)
-
Effect of nitrogen on tetrahydrocannabinol (THC) content in hemp (Cannabis sativa L) leaves at different positions
-
Factors influencing the yield and the quality of hemp (Cannabis sativa L.) essential oil
-
Feasibility of Industrial Hemp Production in the United States Pacific Northwest
-
Agronomic characteristics of some hemp genotypes
-
Cannabis as an illicit crop: recent developments in cultivation and product quality
-
Development of a hemp (Cannabis sativa L.) simulation model. 2. The flowering response of two hemp cultivars to photoperiod
-
Cannabis: an environmentally and economically viable method for climate change mitigation (revised 2001
-
Distortion of Teatree Stems by Twine As a Means to Determine the Number of Years That the Stems Have Been Used to Support Cannabis Plants
-
The inheritance of chemical phenotype in Cannabis sativa L.
-
HISTORICAL AND CULTURAL USES OF CANNABIS AND THE CANADIAN âMARIJUANA CLASHâ
-
Got Powdery Mildew? Get Milk!
-
Hemp: A New Crop with New Uses for North America
-
The biology of Canadian weeds. 119. Cannabis sativa L.
-
Comparing Hemp Seed Yields (Cannabis sativa L.) of an On-Farm Scientific Field Experiment to an On-Farm Agronomic Evaluation Under Organic Growing Conditions in Lower Austria
-
Cold-resistance of hemp (Cannabis Sativa L.)
-
US Patent Application 20070151149 â Methods for altering the level of phytochemicals in plant cells by applying wave lengths of light from 400 nm to 700 nm and apparatus therefore
-
Growth characteristics of Cannabis sativa L. cultivated in a phytotron and in the field
-
Cover Me with Hemp
-
Analysis of Heavy Metal Content in Canabis Leaf and Seed Cultivated in Southern Part of Nigeria
-
Cultivation of Cannabis sativa L. in northern Morocco
-
Fibre crops as alternative land use for radioactively contaminated arable land
-
US Patent Application 20060242899 â Method of cultivating plants
-
Seeding rate and row spacing effect on weed competition, yield and quality of hemp in the Parkland region of Saskatchewan
-
Yield of illicit indoor cannabis cultivation in the Netherlands
-
THE EFFECT OF PLANT DENSITY AND NITROGEN FERTILIZER ON LIGHT INTERCEPTION AND DRY MATTER YIELD IN HEMP (CANNABIS SATIVA L.)
-
Want shorter flowers? Just add liquor
-
Apparent increase in biomass and see productivity in hemp (Cannabis sativa) resulting from branch proliferation caused by the European corn borer (Ostrinia nubilalis)
-
Detection method for the ability of hemp (Cannabis sativa L.) seed germination by the use of 2,3,5-triphenyl-2H-tetrazolium chloride (TTC)
-
Effect of Sowing Date on Growth and Development of Thai Hemp (Cannabis sativa L.)
-
Photosynthetic response of Cannabis sativa L. to variations in photosynthetic photon flux densities, temperature and CO2 conditions
-
The cultivation and utilisation of hemp in Scotland
-
Hemp (Cannabis) Cultivation and Use in the Republic of Korea
-
A PROPAGAGATION SYSTEM FOR CLONING OF HEMP (CANNABIS SATIVA L.) BY SHOOT TIP CULTURE
-
Propagation through alginate encapsulation of axillary buds of Cannabis sativa L â an important medicinal plant
-
Cannabis Yields and Dosage
-
The effect of ultraviolet radiation on the accumulation of medicinal compounds in plants
-
Assessment of Cannabinoids Content in Micropropagated Plants of Cannabis sativa and Their Comparison with Conventionally Propagated Plants and Mother Plant during Developmental Stages of Growth
-
Stable isotope ratios of marijuana. I. Carbon and nitrogen stable isotopes describe growth conditions
-
Effects of Gibberellic Acid on Primary Terpenoids and Delta-Tetrahydrocannabinol in Cannabis sativa at Flowering Stage
-
The effect of ultraviolet radiation on the accumulation of medicinal compounds in plants
-
N, P, and S fertilization effects on industrial hemp in Saskatchewan
-
Characteristics of Cannabis sativa L.: seed morphology, germination and growth characteristics, and distinction from Hibiscus cannabinus L
-
Patterns of Youth Participation in Cannabis Cultivation
-
High Frequency Plant Regeneration from Leaf Derived Callus of High Î9-Tetrahydrocannabinol Yielding Cannabis sativa L.
-
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers
-
The results of an experimental indoor hydroponic Cannabis growing study, using the âScreen of Greenâ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis
-
The case for small-scale domestic cannabis cultivation
-
Stable isotope models to predict geographic origin and cultivation conditions of marijuana
-
Propagation of Elite Cannabis sativa for the Production of Î9-Tetrahydrocannabinol (THC) using Biotechnological Tools
-
Effect of Light Intensity on Photosynthetic Characteristics of High Î9-THC Yielding Varieties of Cannabis sativa L.
-
Cannabis sativa L. Micropropagation in Temporary Immersion Bioreactor System
-
Hydroponics Cultivation Cannabis sativa L. Plants
-
Variation in Î9-THC and other Cannabinoids Content in Field Grown Cannabis sativa L During Different Stages of Growth
-
EVALUATION OF GROWTH INDICES OF HEMP (CANNABIS SATIVA L.) AND SESAME (SESAMUM INDICUM L.) IN INTERCROPPING WITH REPLACEMENT AND ADDITIVE SERIES
-
Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp (Cannabis sativa L.)
-
Photosynthetic response of Cannabis sativa L., an important medicinal plant, to elevated levels of CO2
-
Temperature response of photosynthesis in different drug and fiber varieties of Cannabis sativa L.
-
WITCHESâ BROOM AND PHYLLODY LIKE SYMPTOMS OF DISEASES IN Acalypha indica L. AND Cannabis sativa L. â A NEW REPORT FROM CHAMPARAN, NORTH BIHAR
-
Characterization of Stolbur (16SrXII) Group Phytoplasmas Associated with Cannabis sativa Witchesâ-broom Disease in Iran
-
Changes of photosynthesis-related parameters and productivity of Cannabis sativa under different nitrogen supply
-
Industrial Hemp (Cannabis sativa L.) â a High-Yielding Energy Crop
-
Variations in Photosynthesis, Transpiration, Water Use and Cannabinoid Contents in Field Grown Drug Type Varieties of Cannabis sativa L
-
Study on spectral reflectance characteristics of hemp canopies
-
Factors determining yield and quality of illicit indoor cannabis (Cannabis spp) production
-
The Effect of Electrical Lighting Power and Irradiance on Indoor-Grown Cannabis Potency and Yield
-
Cadmium Tolerance and Bioaccumulation of 18 Hemp Accessions
-
Molecular analysis of genetic fidelity in Cannabis sativa L. plants grown from synthetic (encapsulated) seeds following in vitro storage
-
Small-scale cannabis growers in Denmark and Finland
-
Investigations into the Hypothesis of Transgenic Cannabis
-
Genetic Identification of Female Cannabis sativa Plants at Early Developmental Stage
-
Molecular Analysis of Genetic Stability in Synthetic Seeds Grown Cannabis sativa L Plants
-
Biotechnology of Cannabis sativa L.
-
Variations in Photosynthesis, Transpiration, Water Use and Cannabinoid Contents in Field Grown Drug Type Varieties of Cannabis sativa L
-
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L under Slow Growth Conditions
-
Analysis of Genetic Diversity using SSR Markers and Cannabinoid Contents in Different Varieties of Cannabis sativa L
-
Botany of Cannabis sativa L.: Identification, Cultivation and Processing
-
EVALUATION ALLELOPATHIC EFFECT OF HEMP (CANNABIS SATIVA L.) ON GERMINATION AND GROWTH OF THREE KINDS OF WEEDS
-
Medicinal Genomics Sequences the Cannabis Genome to Assemble the Largest Known Gene Collection of this Therapeutic Plant
-
Attack of the Clones
-
Genome of Marijuana Sequenced and Published
-
Miracle-Gro for marijuana?
-
Feasibility of Using Mycoherbicides to Control Illicit Drug Crops Is Uncertain
-
What Medical Marijuana strain is best for your condition, Sativa or Indica?
-
Cannabis sativa â An Important Subsistence Pollen Source for Apis mellifera
-
Tips On Selecting Cannabis Seeds
-
Common Hemp Crop Pests
-
Growing Hemp
-
Harvesting Hemp
-
Building A Hydroponic Marijuana Garden
-
How-To Guide To Outdoor Marijuana Growing
-
Cannabis â from cultivar to chemovar
-
Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants
-
Why small-scale cannabis growers stay small: Five mechanisms that prevent small-scale growers from going large scale
-
Yield and turnover of illicit indoor cannabis (Cannabis spp.) plantations in Belgium
-
Studies on the Optimization of Agrotechniques to Maximize the Productivity of Two Cannabis Chemotypes Cultivated to Produce Medicinal Grade Plant Material
-
Biomass Yield Studies of Field Cultivated Cannabis sativa L. Plants
-
Propagating Medicinal Plants Under Good Agricultural Practices (GAP): Cannabis sativa L. â A Case Study
-
THE EFFECTS OF JAMONATE ON PLASTIDAL TERPENOIDS ON CANNABIS SATIVA L. AT VEGETATIVE STAGE
-
Temperature and Moisture Content for Storage Maintenance of Germination Capacity of Seeds of Industrial Hemp, Marijuana, and Ditchweed Forms of Cannabis sativa
-
Farmer starts âaccidental cannabis plantationâ
-
The role of child protection in cannabis grow-operations
-
Nematicidal activities of Cannabis sativa L. and Zanthoxylum alatum Roxb. against Meloidogyne incognita
-
A review of the cultivation and processing of cannabis (Cannabis sativa L) for production of prescription medicines in the UK
-
Ecophysiological Aspects of in vitro Propagated Cannabis sativa L. Plants During Acclimatization
-
THE EFFECT OF ABA ON PIGMENTS AND TETRAHYDROCANNABINOL IN CANNABIS SATIVA AT FLOWERING STAGE
-
Potential exposures associated with indoor marijuana growing operations
-
Ethephon application stimulates cannabinoids and plastidic terpenoids production in Cannabis sativa at flowering stage
-
How to Harvest Cannabis Plants
-
Young cannabis confirmed: Cannabinoid content discriminates between drug and hemp forms of cannabis seedlings
-
Indoor Growing: Dirty Fingernails, Better Life
-
CBD strains from Europe Grown Out in California
-
Recommendations for Regulators â Cannabis Operations
-
Let it growâthe open market solution to marijuana control
-
Understanding Cultivar-Specificity and Soil Determinants of the Cannabis Microbiome
-
Study of leaf metabolome modifications induced by UV-C radiations in representative Vitis, Cissus and Cannabis species by LC-MS based metabolomics and antioxidant assays
-
Hashish revival in Morocco
-
Molecular cytogenetic characterization of the dioecious Cannabis sativa with an XY chromosome sex determination system
-
Influence of mevinolin on chloroplast terpenoids in Cannabis sativa
-
N-Acylethanolamines: lipid metabolites with functions in plant growth and development
-
New evidence on the introduction, cultivation and processing of hemp (Cannabis sativa L.) in southern Sweden (link to
-
Amber is Bad ?
-
Induction of male flowers on female plants of Cannabis sativa by gibberellins and its inhibition by abscisic acid
-
Growing medicine: Small-scale cannabis cultivation for medical purposes in six different countries
-
Cannabis, Pesticides and Conflicting Laws: the Dilemma for Legalized States and Implications for Public Health
-
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content
-
Effective Phytoextraction of Cadmium (Cd) with Increasing Concentration of Total Phenolics and Free Proline in Cannabis sativa (L) Plant Under Various Treatments of Fertilizers, Plant Growth Regulators and Sodium Salt
-
Attitudes of cannabis growers to regulation of cannabis cultivation under a nonprohibition cannabis model
-
Production, perceptions, and punishment: Restrictive deterrence in the context of cannabis cultivation
-
Cold acclimation induces distinctive changes in the chromatin state and transcript levels of COR genes in Cannabis sativa varieties with contrasting cold acclimation capacities
-
Cannabis micropropagation â Applications and updates
-
EFFECT OF BIOFERTILIZER, UNDER SALINITY CONDITION ON THE YIELD AND OIL CONTENT OF THREE ECOTYPE OF HEMP (CANNABIS SATIVA L.)
-
Allelopathic effect of fibre hemp (Cannabis sativa L.) on monocot and dicot plant species
-
How to Use Dr. Bronners As Insecticidal Soap
-
Powdery Mildew On Marijuana Plants
-
Music to grow cannabis by
-
Hemp growers cooperativesâ report touts cropâs benefits to coal
-
Weedâs Chronic Energy Use Becomes a Concern
-
Mississippi, home to federal governmentâs official stash of marijuana
-
Before pot yield of their dreams, constant care for fickle plants
-
Why Chocolope? To sell marijuana, you need a clever name
-
What Makes Cannabis Purple?
-
Thomas Jeffersonâs Favorite Plant Is Back in American Soil
-
Federal marijuana bill would legalize some cannabis strains
-
U.S. government to grow 30 times more marijuana this year
-
Marijuana: Italian Army to Grow Cannabis for Medical Purposes
-
Where Americans Smoke and Grow Marijuana (Maps)
-
Legal Pot In The U.S. May Be Undercutting Mexican Marijuana
-
U.S. wonât stop Native Americans from growing, selling pot on their lands
-
Money to burn
-
What is the difference between Indica and Sativa Marijuana Plants?
-
Flowering Week by Week
-
Why Donât We Grow Tomatoes in Basements? The Future of Cannabis Cultivation Is in Greenhouses
-
Effect of Induced Polyploidy on Some Biochemical Parameters in Cannabis sativa L
-
The globalisation of cannabis cultivation: A growing challenge
-
Intrusive growth of primary and secondary phloem fibres in hemp stem determines fibre bundle formation and structure
-
Global patterns of domestic cannabis cultivation: Sample characteristics and patterns of growing across eleven countries
-
The Genetic Structure of Marijuana and Hemp
-
Comparative genomics of a cannabis pathogen reveals insight into the evolution of pathogenicity in Xanthomonas
-
Impacts of surface water diversions for marijuana cultivation on aquatic habitat in four northwestern California watersheds
-
The globalisation of cannabis cultivation: A growing challenge
-
Are Moroccan cannabis growers able to adapt to recent European market trend?
-
Cannabinoids Production by Hairy Root Cultures of Cannabis sativa L.
-
Seized cannabis seeds cultivated in greenhouse: A chemical study by gas chromatographyâmass spectrometry and chemometric analysis
-
Potency 101
-
Assessing the harms of cannabis cultivation in Belgium
-
Cannabis cultivation in Quebec: Between space-time hotspots and coldspots
-
âShould I Buy or Should I Grow?â How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic
-
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L
-
Evaluation of elemental profiling methods, including laser-induced breakdown spectroscopy (LIBS), for the differentiation of Cannabis plant material grown in different nutrient solutions
-
In Vitro Propagation of Cannabis sativa L. Using meta-Topolin
-
Legal issues for German-speaking cannabis growers. Results from an online survey
-
Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana)
-
Molecular cytogenetic analysis of monoecious hemp (Cannabis sativa L) cultivars reveals its karyotype variations and sex chromosomes constitution
-
Expansion of female sex organs in response to prolonged virginity in Cannabis sativa (marijuana)
-
Tyler Markwart: The Case For GMO Cannabis
-
Some Useful Marijuana Cloning Tips
-
What are âfeminizedâ marijuana seeds?
-
Lawyers use âRight to Farmâ amendment to defend cultivation of marijuana
-
Growing hemp for research?
-
RCMP expert admits Mounties lacked data to back up medical pot affidavit
-
Legal Marijuana Cultivation Is Driving A Technology âRevolutionâ In Industrial Agriculture
-
Regulating Pot to Save the Polar Bear: Energy and Climate Impacts of the Marijuana Industry
-
Science Seeks to Unlock Marijuanaâs Secrets
-
The Pot Whisperer: Amherst master grower in demand for cultivation expertise
-
Hereâs The Real Difference Between Sativa & Indica Pot Strains
-
Colombia Supreme Court: Cultivating Up To 20 Marijuana Plants Is Not A Crime
-
Marijuanaâs Pesticide Problem
-
Diseases On Marijuana Plants
-
Hein and Helsmoortel support proposed âkosherâ pot farm in Saugerties
-
Mexico Police Bust Greenhouses With Genetically Modified Pot
-
Marijuana Growing Strategies
-
Water for grass not a big dip: Pot growing would use less than golf courses
-
Natural pest control business gets boost from medical cannabis industry
-
Judge: Missouri right-to-farm doesnât cover marijuana
-
Where Does Your Weed Come From? Breaking Down The DNA Of Sativa And Indica Strains
-
Deer devour hemp crops at southern Oregon farm
-
In the land of towering pot plants, Pakistani farmers brace for a buzz-kill
-
The Great Kentucky Hemp Experiment
-
New Poll Finds Millions Would Like to âGrow Your Ownâ
-
How LEDs Are Making Weed Better
-
Distribution Of Sugars Within Marijuana Plants
-
Is marijuana a single species?: While youâre searching for the perfect high, scientists go deeper
-
Marijuana Grow Closet: Interviewing the Mastermind Behind D.C.âs Next Best Amenity
-
Pot pesticides: What exactly are these chemicals, and why are they banned?
-
Growing Marijuana At A Cellular Level
-
Growing Medical Weed Is NOT a Crime, California Appeals Court Rules
-
Indoor farming: Good for cannabis, not so good for food
-
Study: pot cultivation is hurting the environment
-
Neat âTrickâ Could Save Michigan Marijuana Growers 66% On Electric Bills
-
Swedish man acquitted in court for growing medical marijuana
-
Japanâs First Lady Wants To Be A Hemp Farmer
-
Is It Better To Grow Marijuana Hydroponically Or In Soil?
-
Marijuana Farmers VS Hemp Farmers Over Pollen
-
The Oregonianâs marijuana seedlingsâ gender revealed. What should we name them? (Pot Grow Diary | Day 24)
-
Cannabis sativa: The Plant of the Thousand and One Molecules
-
High Time for Conservation: Adding the Environment to the Debate on Marijuana Liberalization
-
Studying Secondary Growth and Bast Fiber Development: The Hemp Hypocotyl Peeks behind the Wall
-
A Belated Green Revolution for Cannabis: Virtual Genetic Resources to Fast-Track Cultivar Development
-
Applications To Become Registered Under the Controlled Substances Act To Manufacture Marijuana To Supply Researchers in the United States. Policy statement. (click âLink outâ for
-
Farming medical ganja in Jamaica.
-
Hashish in Morocco and Lebanon: A comparative study
-
Medical use of cannabis products : Lessons to be learned from Israel and Canada
-
Chapter 1 â The Botany of Cannabis sativa L
-
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes
-
The influences of cultivation setting on inflorescence lipid distributions, concentrations, and carbon isotope ratios of Cannabis sp.
-
In Vitro Propagation of Cannabis sativa L. and Evaluation of Regenerated Plants for Genetic Fidelity and Cannabinoids Content for Quality Assurance
-
Monitoring Metabolite Profiles of Cannabis sativa L. Trichomes during Flowering Period Using 1H NMR-Based Metabolomics and Real-Time PCR
-
Phytotoxic Effect of Fiber Hemp Essential Oil on Germination of Some Weeds and Crops
-
Use of Embryos Extracted from Individual Cannabis sativa Seeds for Genetic Studies and Forensic Applications
-
Cannabis clubs in Uruguay: The challenges of regulation
-
Cannabis cultivation in Spain: A profile of plantations, growers and production systems
-
Near infrared spectroscopy combined with chemometrics for growth stage classification of cannabis cultivated in a greenhouse from seized seeds
-
Understanding and learning from the diversification of cannabis supply laws
-
Transcriptome differences between fiber-type and seed-type Cannabis sativa variety exposed to salinity
-
âNunsâ fight to keep their marijuana-based business in California
-
Latin Americaâs biggest medical cannabis farm sprouts in Chile
-
Perfect pot? U of Guelph researchers working to grow marijuana optimally
-
How To Save Water When Growing Marijuana Plants Outdoors
-
State Regulators Weigh in on Pesticides Like Never Before
-
Buffington: Iâm Growing Marijuana
-
Buffington: Medical Marijuana, Part 2
-
Clone Your Favorite Marijuana Plants
-
Marijuanaâs Mad Scientist Is Changing the Weed Game
-
Which Pesticides Are Allowed on Marijuana?
-
Cannabiz: Can I Sell Marijuana to Dispensaries?
-
Timeline: The hemp odyssey of Alex White Plume
-
Stretching Stems On Your Marijuana Plants
-
Marijuanaâs Dirty Secret: Energy Consumption
-
What is the Best Way to Cure Cannabis Flowers?
-
The stoned soldiers of Santa Cruz
-
Pot fences make good neighbors
-
Father advocates for exemption to pot ordinance to treat sonâs severe epilepsy
-
Where Do Marijuana Strain Names Come From? Origins of Sour Diesel, OG Kush and More
-
The crazy, complicated world of âorganicâ weed
-
How To Grow Dense And Bushy Marijuana Plants
-
Guy growing cannabis illegally is now a multi-millionaire and paying his taxes
-
Stoned sheep cause mayhem after eating marijuana plants
-
Marijuana May Boost Brain Performance
-
Science For Space Farming Is Also Being Used to Grow Weed
-
Federal agency wonât include pot in annual crop statistics
-
This woman teaches you how to legally grow weed in your home
-
Marijuana campaign tactic: Buy American, not Mexican
-
The Latest: California lawmakers OK water for pot growers
-
The Sweet Spot
-
An elderly couple found help for a brain injury through marijuana â then police found 20 pot plants growing at their home
-
Fake âOrganicâ Pot Gardening Products Yanked From Oregon Stores
-
Farmers are planting marijuana to clean up the land contaminated by Europeâs biggest steel mill
-
Quiz: Do your neighbors think youâre running a marijuana operation?
-
High Science: Tissue Culture Cultivation Is The Future Of Growing
-
Pot Not the New Almond
-
Marijuana industry brought to a standstill by new pesticide testing regulations
-
Cannabis farmers hidden in Indiaâs Himalayas
CUSHINGâS SYNDROME (1)
CYSTITIS (10)
-
The afferent system and its role in lower urinary tract dysfunction
-
Activation of Cannabinoid Receptor 2 Inhibits Experimental Cystitis
-
Treatment with a Cannabinoid Receptor 2 Agonist Decreases Severity of Established Cystitis
-
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase
-
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase
-
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis
-
Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis
-
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats
-
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease
-
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase